home / stock / kdmn / kdmn short
Short Information | Kadmon Holdings Inc. (NYSE:KDMN)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 522,296 |
Total Actual Volume | 38,304,323 |
Short Trends | |
---|---|
Cover Days | 20 |
Short Days | 0 |
No Change Days | 0 |
Averages | |
---|---|
Average Short Volume | 26,115 |
Average Short Percentage | 1.38% |
Is there a KDMN Short Squeeze or Breakout about to happen?
See the KDMN Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
10-26-2020 | $3.47 | $3.395 | $3.58 | $3.32 | 1,334,624 | 17,010 | 1.27% |
10-23-2020 | $3.49 | $3.53 | $3.57 | $3.44 | 854,287 | 6,581 | 0.77% |
10-22-2020 | $3.43 | $3.5 | $3.59 | $3.4 | 2,643,551 | 12,158 | 0.46% |
10-21-2020 | $3.67 | $3.42 | $3.72 | $3.41 | 2,904,642 | 125,165 | 4.31% |
10-20-2020 | $3.99 | $3.71 | $3.99 | $3.65 | 3,373,539 | 58,353 | 1.73% |
10-19-2020 | $4.01 | $3.9 | $4.09 | $3.87 | 2,717,434 | 5,147 | 0.19% |
10-16-2020 | $4.09 | $4 | $4.13 | $3.95 | 1,408,679 | 19,526 | 1.39% |
10-15-2020 | $3.87 | $4.12 | $4.18 | $3.86 | 1,323,749 | 7,160 | 0.54% |
10-14-2020 | $3.98 | $4.03 | $4.1 | $3.93 | 1,321,334 | 4,214 | 0.32% |
10-13-2020 | $3.89 | $3.99 | $4.05 | $3.86 | 2,018,379 | 9,924 | 0.49% |
10-12-2020 | $4.15 | $3.94 | $4.15 | $3.89 | 1,545,806 | 71,665 | 4.64% |
10-09-2020 | $4.14 | $4.14 | $4.195 | $4.09 | 1,135,871 | 13,086 | 1.15% |
10-08-2020 | $4.11 | $4.08 | $4.19 | $4.05 | 844,384 | 36,390 | 4.31% |
10-07-2020 | $4.11 | $4.06 | $4.14 | $4.02 | 1,349,786 | 5,089 | 0.38% |
10-06-2020 | $4.1 | $4.03 | $4.165 | $4.015 | 1,773,548 | 8,176 | 0.46% |
10-05-2020 | $3.98 | $4.1 | $4.18 | $3.94 | 1,448,657 | 7,734 | 0.53% |
10-02-2020 | $3.98 | $3.94 | $4.11 | $3.92 | 1,410,841 | 9,553 | 0.68% |
10-01-2020 | $3.99 | $4.06 | $4.18 | $3.94 | 2,528,609 | 37,154 | 1.47% |
09-30-2020 | $3.72 | $3.92 | $3.93 | $3.67 | 3,920,622 | 19,833 | 0.51% |
09-29-2020 | $3.77 | $3.72 | $3.77 | $3.605 | 2,445,981 | 48,378 | 1.98% |
News, Short Squeeze, Breakout and More Instantly...
- REZUROCK™ (belumosudil) 200 mg once daily (QD) tablets are now commercially available for shipment to prescribed patients in the United States - - Execution of strategic launch strategy underway; Third quarter REZUROCK net sales $12.2 million - - Sanofi acquisition of Kadm...
NEW YORK, NY / ACCESSWIRE / October 1, 2021 / Kadmon Holdings, Inc. (NASDAQ:KDMN) today announced it will present data from the ongoing Phase 1 clinical trial of KD033, its anti-PD-L1/IL-15 fusion protein, in patients with metastatic or locally advanced solid tumors, in addition to other IL-...
FinancialBuzz.com’s latest The Buzz Show: Featuring Our Corporate News Recap on “Kadmon Holdings, Inc. Skyrockets Amid Entering Definitive Merger Agreement with Sanofi Kadmon Holdings, Inc. (NASDAQ: KDMN) surged 73% in premarket trading after entering...